Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis

Detalles Bibliográficos
Autores principales: Cai, Lin, Zhang, Jian-Zhong, Zheng, Min, Zhang, Shi-Fa, Patekar, Manmath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577655/
https://www.ncbi.nlm.nih.gov/pubmed/34748527
http://dx.doi.org/10.1097/CM9.0000000000001710
_version_ 1784596104047755264
author Cai, Lin
Zhang, Jian-Zhong
Zheng, Min
Zhang, Shi-Fa
Patekar, Manmath
author_facet Cai, Lin
Zhang, Jian-Zhong
Zheng, Min
Zhang, Shi-Fa
Patekar, Manmath
author_sort Cai, Lin
collection PubMed
description
format Online
Article
Text
id pubmed-8577655
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-85776552021-11-10 Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis Cai, Lin Zhang, Jian-Zhong Zheng, Min Zhang, Shi-Fa Patekar, Manmath Chin Med J (Engl) Clinical Observations Lippincott Williams & Wilkins 2021-11-05 2021-09-15 /pmc/articles/PMC8577655/ /pubmed/34748527 http://dx.doi.org/10.1097/CM9.0000000000001710 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Clinical Observations
Cai, Lin
Zhang, Jian-Zhong
Zheng, Min
Zhang, Shi-Fa
Patekar, Manmath
Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_full Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_fullStr Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_full_unstemmed Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_short Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_sort efficacy and safety of secukinumab over 52 weeks in chinese psoriasis patients with concomitant psoriatic arthritis
topic Clinical Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577655/
https://www.ncbi.nlm.nih.gov/pubmed/34748527
http://dx.doi.org/10.1097/CM9.0000000000001710
work_keys_str_mv AT cailin efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
AT zhangjianzhong efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
AT zhengmin efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
AT zhangshifa efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
AT patekarmanmath efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis

Ejemplares similares